Lifei Cheng is the Founder & CEO of MedTecX, a global medtech accelerator based in China. MedTecX accelerates access of best value therapies to every patient, starting with China.

Lifei Cheng was Vice President of Business Development & Ventures at Medtronic during 2012-2018. Lifei led strategic investments and the integration of Covidien into Medtronic in Greater China. Lifei founded the Medtronic-Sequoia China ventures, a $60 million fund dedicated to investments in medical technology and service startups.  In addition, Lifei started three new ventures that scaled into new businesses and growth platforms.

Lifei Cheng established and headed up Business Development at MSD / Merck China.  Lifei built and led a cross function and cross border team to generate profitable growth through local investment and partnership, including the Joint Venture with Simcere.  Lifei joined Merck in the United States in 2003 and headed a Portfolio Management group for Merck’s R&D pipeline.

Lifei Cheng holds an executive MBA from The Wharton School.  He obtained his Ph.D. in Engineering and Economics from Carnegie Mellon University.  Lifei graduated from Tsinghua University with dual B.S. degrees in Engineering and Business.